Epitomee Medical Ltd
TASE:EPIT
Cash Flow Statement
Cash Flow Statement
Epitomee Medical Ltd
| Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||
| Net Income |
(12)
|
(19)
|
(15)
|
(10)
|
(6)
|
(6)
|
(1)
|
0
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
1
|
1
|
1
|
0
|
1
|
|
| Change in Deffered Taxes |
0
|
0
|
0
|
0
|
(10)
|
(10)
|
0
|
0
|
|
| Other Non-Cash Items |
4
|
10
|
6
|
(0)
|
7
|
7
|
(7)
|
(8)
|
|
| Change in Working Capital |
1
|
0
|
(0)
|
1
|
(10)
|
(9)
|
(0)
|
(1)
|
|
| Cash from Operating Activities |
(6)
N/A
|
(8)
-45%
|
(9)
-13%
|
(9)
+4%
|
(8)
+12%
|
(8)
+4%
|
(8)
-9%
|
(8)
+5%
|
|
| Investing Cash Flow | |||||||||
| Capital Expenditures |
(0)
|
(1)
|
(4)
|
(5)
|
(4)
|
(3)
|
(5)
|
(5)
|
|
| Other Items |
16
|
9
|
(9)
|
(24)
|
(8)
|
9
|
15
|
18
|
|
| Cash from Investing Activities |
15
N/A
|
8
-47%
|
(13)
N/A
|
(29)
-118%
|
(12)
+57%
|
6
N/A
|
10
+76%
|
13
+30%
|
|
| Financing Cash Flow | |||||||||
| Net Issuance of Common Stock |
50
|
50
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
|
| Cash from Financing Activities |
50
N/A
|
50
0%
|
(0)
N/A
|
(0)
-36%
|
(0)
-2%
|
(0)
+10%
|
(1)
-25%
|
(1)
-6%
|
|
| Change in Cash | |||||||||
| Effect of Foreign Exchange Rates |
0
|
(5)
|
(5)
|
(0)
|
0
|
(0)
|
(0)
|
1
|
|
| Net Change in Cash |
59
N/A
|
45
-25%
|
(28)
N/A
|
(38)
-35%
|
(20)
+47%
|
(2)
+88%
|
1
N/A
|
6
+512%
|
|
| Free Cash Flow | |||||||||
| Free Cash Flow |
(6)
N/A
|
(9)
-51%
|
(13)
-41%
|
(14)
-4%
|
(12)
+12%
|
(11)
+9%
|
(13)
-18%
|
(13)
+2%
|
|